Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China

World Journal of Gastroenterology

Volumn 6, Issue 5, 2000, Pages 750-753

  Wang, X J ^a   Yuan, S L ^a   Li, C P ^a   Iida, N ^a   Oda, H ^a   Aiso, S ^a   Ishikawa, T ^a  

^a WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CARDIA CARCINOMA; CHINA; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR SUPPRESSOR GENE;

EID: 0033786432     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i5.750     Document Type: Article

References (44)

1. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia
2. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53
3. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
4. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
5. Adenocarcinoma of the esophagus and gastric cardia: Is there progress in the face of increasing cancer incidence?
6. The expression of c-src gene in the carcinogenesis process of human cardia adenocarcinoma
7. An immunohistochemical observation of src gene product in cardiac carcinoma
8. The distribution of esophageal and cardiac carcinoma and precanceous of 2238
9. Changing patterns in gastric carcinoma
10. Comparative studies on epithelial lesions at gastric cardia and pyloric antrum in subjects from a high incidence area for esophageal cancer in Henan, China
11. The value of flow cytometric analysis in patients with gastric cancer
12. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas
13. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer
14. P53 alterations and cell proliferation in esophageal epithelia among subjects from high and low incidence areas of esophageal cancer
15. Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xi' an
16. Changes of p53 protein blood level in esophageal cancer patients and normal subjects from a high incidence area in Henan, China
17. p53 immunostaining positive cells correlated positively with S phase cells as measured by BrdU in the esophageal precancerous lesions from the subjects at high incidence area for esophageal cancer in northern China
18. p53 mutations in esophageal tumors from high-incidence areas of China
19. Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy
20. Changes of p53 and Waf1p21 and cell proliferation in esophageal carcinogenesis
21. Molecular biology of Barrett's esophagus and esophageal cancer: Role of p53
22. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China
23. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
24. A mutational hot spot in the p53 gene is associated with hepatoblastomas
25. Prevalence of p53 mutations and protein expression in esophageal cancers in southern Thailand
26. IARC Database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualization stools
27. Overexpression and mutations of tumor suppressor gene p53 in hepatocellular carcinoma
28. Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma
29. Codon 249 mutations of p53 gene in non-neoplastic liver tissues
30. Mutation of p53 gene in human cancers of the esophagus and gastric cardia
31. Mutations of the k-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy
32. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma
33. Timing of p53 mutations during astrocytoma tumor
34. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53
35. Correlation between the status of the p53 gene and survival in patients with stage I non-small-cell lung carcinoma
36. p53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus
37. Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event
38. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
39. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
40. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract
41. Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer
42. The p53-mdm-2 autoregulatory feedback loop
43. Relationship between human papillomavirus infection and the development of esophageal carcinoma
44. Etiologic relationship between human papillomavirus and esophageal cancer